Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
104 participants
INTERVENTIONAL
2007-01-31
2009-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Measurement of Joint Attention Fluency
NCT01643343
Evaluation of a Program to Enhance Ophthalmic Compliance in Children and Adolescents with Special Needs
NCT06717282
The Effects of Relational Letter Writing
NCT05194683
Impact of Exposure to Television and Electronic Devices on Attention and Language in Children
NCT05659238
Enhancing Speech Fluency With Non-invasive Brain Stimulation in Developmental Stuttering
NCT02288598
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This dataset involves a conversation between two strangers that took place 45 minutes after drug administration. While Liu et al. coded the video for markers of interpersonal distance (physical distance, eye contact, conversational intimacy), the investigators seek to analyse oxytocin's effects on non-verbal communication of affiliative and sexual cues (e.g., smiles, lip puckers). Based on findings that oxytocin's effects depend on context, the investigators will explore these relationships as a function of the conversational context (where participants converse with each other using low-, medium-, and high-intimacy topics, or in an unstructured conversation).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
BASIC_SCIENCE
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Oxytocin
24IU Syntocinon, delivered in a single nose via a nasal spray
Oxytocin
Administration of the hormone oxytocin
Placebo
Matched nasal spray
Placebos
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Oxytocin
Administration of the hormone oxytocin
Placebos
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* history of epilepsy, severe depression, severe anxiety, or psychosis;
* smoking more than 15 cigarettes a day;
* addicted to illegal substances.
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Yale-NUS College
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jean Liu
Assistant Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of New South Wales
Sydney, New South Wales, Australia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IG15-B052
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.